Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Giam (Dundee, United Kingdom), H. Richardson (Dundee, United Kingdom), A. Smith (Cambridge, United Kingdom), H. Keir (Dundee, United Kingdom), D. Cassidy (Dundee, United Kingdom), S. Finch (Dundee, United Kingdom), S. Aliberti (Milan, Italy), O. Sibila (Barcelona, Spain), A. Shoemark (Dundee, United Kingdom), J. Chalmers (Dundee, United Kingdom). Immunometabolic markers and the sputum microbiome in bronchiectasis. 1314

Member's Comments

No comment yet.

Related content which might interest you: The microbiome in bronchiectasis Source: ERS Lung Science Conference 2019 Year: 2019 The bronchiectasis microbiome Source: Eur Respir Monogr 2018; 81: 82-98 Year: 2018 Sputum neutrophils are related to functional status in non-cystic fibrosis bronchiectasis in subjects in airway colonization Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Is induced sputum more useful than expectorated sputum to identify respiratory pathogens in children with cystic fibrosis? Source: Eur Respir J 2007; 30: Suppl. 51, 31s Year: 2007 Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis Source: Eur Respir J 2009; 33: 361-364 Year: 2009 The microbiome of COPD in protected, bronchoscopic airway samples Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Non-CF bronchiectasis: cell population in sputum Source: Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation Year: 2007 Inflammatuary markers in induced sputum and clinical parameters in children with non-cystic fibrosis bronchiectasis Source: Annual Congress 2004 - Chronic respiratory illness in childhood Year: 2004 Sputum proteomics identifies distinct endotypes of exacerbations in bronchiectasis Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers Year: 2020 Sputum bacterial concentrations and exacerbations of non cystic fibrosis bronchiectasis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Sputum proteomics of CF, BE and COPD with or without NTM infections Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease Year: 2021 Spectrum of sputum microflora during infectious exacerbation of bronchial asthma Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009 Sputum neutrophils are related to functional status in non-cystic fibrosis bronchiectasis Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Inflammatory markers in sputum of patients with cough variant asthma Source: Eur Respir J 2002; 20: Suppl. 38, 584s Year: 2002 The difference of airway microbiota between nontuberculous mycobacteria lung disease and bronchiectasis Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Correlation between sputum cytology and lung physiology in asthma and COPD subjects in Indian population Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002 Chronic sputum production in COPD is a marker for airway inflammation and colonisation Source: Eur Respir J 2004; 24: Suppl. 48, 306s Year: 2004 Bacterial flora in sputum and relationship with lung function in patients with acute exacerbation of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 576s Year: 2006 Molecular characterisation of bacteria in sputum samples from severe asthma Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008